Research Article
Sodium Butyrate Plus EGF and PDGF-BB Aids Cutaneous Wound Healing in Diabetic Mice
Table 2
Time-line for STZ treatment, wounding, topical application of growth factor(s) and Na-Bu, and tissue harvest.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Day 0 is the beginning of the experiments. The animals were 6 weeks old and they were starved (STR) for 20 h prior to the induction of diabetes. STZ, daily injection of streptozotocin at a concentration of 40 mg/Kg body weight for consecutive 5 days (D1 to D5). Ten days (D6 to D15) after the last STZ injection, the wounds (W) were created and the day of the wounding is taken as W1; TT, various topical treatments as given in Table 4. G, measurement of glucose levels on the days after beginning the experiment; TH, days when the tissues were harvested for western blotting. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||